Skip to content
Matrix Global Advisors
Matrix Global Advisors
  • Home
  • About
  • News
  • Our Work
  • Contact
  • Home
  • About
  • News
  • Our Work
  • Contact
Mar252020
Events

MGA’s Alex Brill Serves as a Panelist for “Biosimilars: Breaking Through the Barriers” Symposium

Skylar Jeremias | The Center for Biosimilars

Alex Brill was one of the panelists discussing his “commitment to expand biosimilar use in the United States and how physicians and government officials are looking to help.

[He] brought up that most legislation for biosimilars includes policies that focus on Medicare plans rather than employers and individual patients because “of the way Washington works…to encourage policymakers to pursue the policies that will drive biosimilar utilization by those types of things that will save money for the federal government.””

Read Here

March 25, 2020Category: Events
Tags: biosimilarsdrug pricepanelistprice decreasessymposium

Post navigation

PreviousPrevious post:New Analysis Situates COVID-19 Alongside 1918 Pandemic, Predicts 12 Million–26 Million HospitalizationsNextNext post:Efforts to Combat E-Cigarette Misuse Could Backfire
  • Analysis(29)
  • Books(2)
  • Events(13)
  • Interviews(35)
  • News(45)
  • Op-Eds(60)
  • Press Releases(2)
  • Testimony(18)
  • The American Rescue Plan’s Likely Cost is Way More Than $1.9 Trillion
    March 4, 2021
  • Pick Your Child Tax Credit
    March 2, 2021
  • The Tax Benefits of Parenthood: A History and Analysis of Current Proposals
    February 23, 2021
  • MGA Analysis of Potential Savings from Complex Generics Cited in Multiple Publications
    February 12, 2021

Website Design and Developed by DreamBig Creative